Pers nieuws

World-class collaboration receives €37.5 million for regenerative medicine using smart materials

Alternatives to antibiotics: Adapting phages to overcome bacterial defense barriers

Collaborating researchers from University Medical Center Utrecht and Delft University of Technology have received funding from the Dutch Research Council (NWO) to develop more broadly acting bacteriophages. With help of such adapted phages, the researchers want to overcome bacterial defense barriers, which are important mechanisms in the bacterial resistance against bacteriophages.

Decoding the brain - Loss of use does not mean loss of function

Imagine you are completely immobile, only able to blink to communicate with the outside world. This is the reality for people with locked-in syndrome, a condition where patients are completely paralysed except for their eyes, while being fully conscious. Mark Bruurmijn spent his PhD working on building a brain-computer interface, helping these patients to communicate. On April 11th Bruurmijn receives his doctorate for his work on decoding the brain.

"I'm a real tech guy"

How do diseases develop? How can we recognize them more quickly? And how can we treat them in a more targeted way? By analyzing very large amounts of molecular data with the latest developments in artificial intelligence (AI). This is what Jeroen de Ridder is dedicated to. As of 1 April 2024, he has been appointed as professor of bioinformatics in molecular biology at UMC Utrecht, within the Strategic Program Cancer.

GRIPonMASH received significant EU funding to improve prevention and care of Metabolic dysfunction-Associated SteatoHepatitis (MASH)

GRIPonMASH, a newly founded consortium consisting of 27 European institutions and companies, has bundled resources to bring about a transformational change in the detection and treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Supported by the Innovative Health Initiative Joint Undertaking (IHI JU), the consortium will focus on developing the GRIPonMASH Diagnostic Platform which will allow early detection of patients with MASH, better patient stratification and personalized lifestyle advice.

Tackling cancer: healthy lifestyle and yoga

Do healthy lifestyle habits help prevent neuroendocrine tumors? Does yoga reduce the side effects of hormone therapy in women with breast cancer? Researchers at UMC Utrecht are addressing these questions in two new studies, for which they have received grants from the World Cancer Research Fund.

Disturbances in sensory neurons may alter transient pain into chronic pain

Researchers from the Center for Translational Immunology at University Medical Center Utrecht (the Netherlands) have identified that a transient inflammatory pain causes mitochondrial and redox changes in sensory neurons that persist beyond pain resolution.

Appointment of Scientific Directors and Director EWUU Education to strengthen the alliance between Eindhoven, Wageningen and Utrecht

The alliance of TU/e, WUR, UU, and UMC Utrecht (EWUU) has appointed two Scientific Directors and a Director EWUU Education to strengthen the collaboration between the four institutes in Eindhoven, Wageningen and Utrecht.

Number of animal experiments at Utrecht University and UMC Utrecht again virtually unchanged

The number of animal experiments at Utrecht University and the UMC Utrecht has remained almost the same this year. There is a minimal decrease from 20.576 in 2021 to 20.436 in 2022. This appears from the joint 2022 Annual Report on Animal Experiments. 

UMC Utrecht investigates the link between RSV infection and chronic respiratory tract disease

UMC Utrecht will lead an international consortium that will try to answer a key question that’s in the mind of many pediatricians, infectiologists, pulmonologists and other health professionals: “Why are children that had an RSV infection in early childhood at increased risk of developing asthma later in life?”